Patent application number | Description | Published |
20100203032 | ORLISTAT COMPOSITIONS - A pharmaceutical combination or composition containing a lipase inhibitor, preferably orlistat, and a bile acid sequestrant is useful for treating obesity. | 08-12-2010 |
20110275706 | Pharmaceutical Compositions Containing Lipase Inhibitors - A pharmaceutical composition comprises at least one inhibitor of lipases, preferably an inhibitor of gastrointestinal and pancreatic lipases, such as orlistat, at least one surfactant, and at least one dispersant. | 11-10-2011 |
20130253289 | DIAGNOSTIC DEVICE - An improved diagnostic analyte monitoring device has partially retractable hollow guide needles for the intradermal placement of diagnostic elements fixedly connected to measuring means within this device obviating the need to remove the guide needle and to connect the diagnostic elements to measuring means after placement into the skin. A flexible surface adhering to the skin serves for the subcutaneous implantation of the diagnostic elements within the guide needles and partial retraction of the guide needles exposes the active surface to body fluid, actuated by means designed for easy handling and safe operation. Concentration-time profiles of endogenous and exogenous analytes measured with the device are used to improve drug treatment modalities on an individualized basis. | 09-26-2013 |
20130324884 | SYRINGE TYPE PUMP - In a syringe type pump with a barrel ( | 12-05-2013 |
20140114211 | DERMALLY AFFIXED DEVICE FOR INTRAVENOUS ACCESS - An improved, injection or blood removal device for intravenous access has a port with a septum at the exterior end of an intravenous catheter, a coupling element having an adhesive surface for securing attachment onto the skin, an injection or blood sampling unit, a connecting cannula piercing the septum of the port, and means to secure functional assembly. Attachment of the device to the skin covering or close to the intravenous puncture site and without long communicating tubes allows ambulant injection of drugs or measuring of concentration-time profiles of exogenous and endogenous analytes to improve treatment modalities on an individualized basis. | 04-24-2014 |
20150105691 | MANUAL PRESSURE ACTIVATED APPLICATION MECHANISM - A skin insertion mechanism of a needle fixedly positioned in a needle holder with connective means to an injection or analysis system has a skin attachment plate coated with an adhesive layer and a spacer mechanism keeping in the ready-to-use position the skin attachment plate spaced away from the needle support covering the needle. Subcutaneous insertion of the needle is effected by attachment with the adhesive layer to the skin and releasing the spacer mechanism by applying a pre-set trigger point pressure against the skin. | 04-16-2015 |
20150141776 | SUBCUTANEOUS NEEDLE INSERTION MECHANISM - A subcutaneous access device has a skin attachment plate coated with an adhesive layer. The skin attachment plate is moveably linked by a retraction mechanism to a needle support with fixedly positioned needles. In the ready-to-use position the skin attachment plate is spaced away from the needle support and covers the fixedly positioned needles. Subcutaneous insertion of the needles is effected by attachment of the skin attachment plate with the adhesive layer to the skin and releasing the retraction mechanism, thus triggering the pulling of the attached skin with high velocity against the tip of the needles. | 05-21-2015 |
20150174401 | SUB-EPIDERMAL ELECTRIC WARNING DEVICE - A sub-epidermal electric warning device has electrodes penetrating through the patient's epidermis and bipolar electric warning signals are transmitted to the sub-epidermal tissue by these electrodes. A device for surveillance of vital signs, analyte levels, or treatment parameters is using a sub-epidermal electric warning device for notifying the patient in situations requiring intervention. | 06-25-2015 |